Cellular Interaction and Mechanism of Oncogenesis
Polyomaviruses were previously classified within the Papovaviridae family, but today they form a separate, independent group. Their interaction with the host depends on whether the host is natural or foreign:
- In natural host cells, the virus undergoes a productive infection. Virions actively assemble in the cell nucleus and are subsequently released, causing lysis (destruction) of the infected cell.
- In foreign hosts (such as heterologous cell cultures or newborn animals of other species), the virus behaves differently. Its DNA integrates into the host cell genome, and exclusively early proteins are expressed. This stimulates the formation of tumors with various histological structures.
T-antigen plays a key role in the process of malignant transformation. This viral factor binds to the host tumor suppressor protein p53 and blocks its function. As a result, the cell loses control over the cell cycle and begins to divide uncontrollably.
Human Polyomaviruses: BK and JC Viruses
Despite their high prevalence (most humans are infected), clinically apparent diseases develop primarily against the background of severe immunosuppression. These viruses act as typical opportunistic pathogens.
- BK Virus
This agent was first isolated from the urine of kidney transplant recipients. The virus exhibits a tropism for the urinary tract and poses a serious threat specifically to renal graft recipients, causing severe graft dysfunction.
- JC Virus
This pathogen was isolated from the brain tissue of patients suffering from progressive multifocal leukoencephalopathy (PML).
- Tropism: The JC virus specifically targets glial cells of the central nervous system.
- Pathogenesis: In the setting of impaired cell-mediated immunity, the virus destroys oligodendrocytes, leading to massive demyelination of the cerebral white matter.
- Oncogenicity: Under laboratory conditions (in hamsters and monkeys), it is capable of inducing brain tumors.
Simian Vacuolating Virus 40 (SV40)
The SV40 virus is the classic prototype of the entire Polyomaviridae family. It was discovered in rhesus macaque kidney cell cultures. Notably, in its natural host cells, it causes neither a cytopathic effect (CPE) nor transformation. However, when introduced into African green monkey kidney cell cultures, the virus causes pronounced cytoplasmic vacuolization and subsequent cell death.
Oncogenic Activity: In certain animals (rats, hamsters, marmosets), SV40 is a potent oncogene, inducing tumors. However, it is entirely non-pathogenic to humans.
The historical mass polio vaccination campaigns provided large-scale epidemiological proof of the virus's safety for humans. The vaccine preparations were cultured on macaque kidney cells and were found to be contaminated with SV40. Despite tens of millions of people receiving the vaccine, subsequent multi-year monitoring revealed no surge in oncological diseases among the vaccinated population.
Virion Structure and Diagnostics
Polyomaviruses are small, non-enveloped particles. Their genome consists of circular double-stranded DNA encoding two types of proteins:
- Early (non-structural): small t-antigen and large T-antigen.
- Late (capsid): proteins VP1, VP2, and VP3. The VP1 protein is the major structural component of the capsid and is responsible for attaching the virion to the target cell membrane.
Laboratory Diagnosis of Infection:
- Molecular genetic testing: detection of specific viral DNA using polymerase chain reaction (PCR).
- Serological testing: detection of antibodies in the patient's serum (ELISA, complement fixation test, neutralization assay). Notably, antibodies are usually detected in relatively low titers.
- Virological (culture) method: inoculation of material onto human embryonic or African green monkey kidney cells. The presence of the virus is confirmed by the development of a characteristic cytopathic effect (vacuolization, plaque formation). A neutralization test is used for precise identification.
To date, specific prophylaxis (vaccines) against polyomaviruses has not been developed.